Moors & Cabot’s Stryker SYK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.25M Buy
9,902
+137
+1% +$49.2K 0.14% 145
2025
Q4
$3.43M Buy
9,765
+41
+0.4% +$14.9K 0.15% 136
2025
Q3
$3.59M Sell
9,724
-696
-7% -$269K 0.16% 128
2025
Q2
$4.12M Sell
10,420
-136
-1% -$50.9K 0.19% 106
2025
Q1
$3.93M Sell
10,556
-130
-1% -$49.5K 0.2% 104
2024
Q4
$3.85M Buy
10,686
+43
+0.4% +$15.9K 0.18% 111
2024
Q3
$3.84M Buy
10,643
+40
+0.4% +$13.8K 0.19% 107
2024
Q2
$3.61M Sell
10,603
-104
-1% -$35.2K 0.19% 107
2024
Q1
$3.83M Sell
10,707
-729
-6% -$245K 0.21% 102
2023
Q4
$3.42M Sell
11,436
-312
-3% -$87.6K 0.21% 107
2023
Q3
$3.21M Sell
11,748
-45
-0.4% -$12.9K 0.22% 103
2023
Q2
$3.6M Sell
11,793
-548
-4% -$158K 0.24% 99
2023
Q1
$3.52M Sell
12,341
-2,306
-16% -$612K 0.24% 100
2022
Q4
$3.58M Buy
14,647
+21
+0.1% +$4.76K 0.25% 92
2022
Q3
$2.96M Buy
14,626
+34
+0.2% +$7.15K 0.23% 97
2022
Q2
$2.9M Buy
14,592
+129
+0.9% +$30.3K 0.21% 105
2022
Q1
$3.87M Buy
14,463
+1,177
+9% +$305K 0.24% 98
2021
Q4
$3.55M Sell
13,286
-55
-0.4% -$14.4K 0.22% 99
2021
Q3
$3.52M Buy
13,341
+517
+4% +$138K 0.22% 101
2021
Q2
$3.33M Sell
12,824
-374
-3% -$95.6K 0.23% 96
2021
Q1
$3.21M Buy
13,198
+33
+0.3% +$7.91K 0.25% 93
2020
Q4
$3.23M Sell
13,165
-6,740
-34% -$1.53M 0.27% 86
2020
Q3
$4.15M Sell
19,905
-2,341
-11% -$455K 0.39% 61
2020
Q2
$4.01M Sell
22,246
-2,709
-11% -$500K 0.43% 57
2020
Q1
$4.16M Buy
24,955
+880
+4% +$172K 0.6% 37
2019
Q4
$5.05M Buy
24,075
+9,981
+71% +$2.07M 0.51% 45
2019
Q3
$3.05M Buy
14,094
+5,560
+65% +$1.19M 0.34% 77
2019
Q2
$1.75M Sell
8,534
-184
-2% -$35.1K 0.22% 111
2019
Q1
$1.73M Sell
8,718
-627
-7% -$113K 0.23% 109
2018
Q4
$1.47M Sell
9,345
-468
-5% -$78.3K 0.23% 113
2018
Q3
$1.74M Buy
9,813
+102
+1% +$17.4K 0.21% 120
2018
Q2
$1.64M Sell
9,711
-775
-7% -$130K 0.22% 120
2018
Q1
$1.69M Sell
10,486
-169
-2% -$27.2K 0.22% 119
2017
Q4
$1.65M Sell
10,655
-299
-3% -$45.6K 0.22% 120
2017
Q3
$1.55M Sell
10,954
-220
-2% -$31.5K 0.22% 121
2017
Q2
$1.55M Sell
11,174
-49
-0.4% -$6.72K 0.26% 115
2017
Q1
$1.47M Sell
11,223
-1,249
-10% -$158K 0.25% 110
2016
Q4
$1.5M Sell
12,472
-567
-4% -$65.2K 0.25% 111
2016
Q3
$1.52M Buy
13,039
+576
+5% +$67.1K 0.25% 105
2016
Q2
$1.49M Buy
12,463
+981
+9% +$110K 0.26% 101
2016
Q1
$1.23M Sell
11,482
-908
-7% -$89.5K 0.22% 117
2015
Q4
$1.15M Buy
12,390
+3
+0% +$287 0.21% 126
2015
Q3
$1.16M Sell
12,387
-497
-4% -$49.2K 0.22% 127
2015
Q2
$1.23M Sell
12,884
-848
-6% -$80.4K 0.2% 126
2015
Q1
$1.26M Buy
13,732
+354
+3% +$33K 0.21% 117
2014
Q4
$1.26M Buy
13,378
+501
+4% +$44.4K 0.21% 116
2014
Q3
$1.03M Buy
12,877
+77
+0.6% +$6.33K 0.18% 138
2014
Q2
$1.07M Buy
12,800
+2,555
+25% +$209K 0.18% 131
2014
Q1
$835K Buy
+10,245
New +$815K 0.21% 123

Other funds holding SYK

Moors & Cabot's SYK Position: Q1 2026 in Review

Moors & Cabot increased its Stryker (SYK) stake by 1.4% in Q1 2026, buying an estimated $49.2K and bringing the position to 9,902 shares worth $3.25M. The position accounts for 0.14% of the portfolio, ranked #145.

Moors & Cabot first reported a position in SYK in Q1 2014 and has held it in 49 quarters since. The position peaked at $5.05M in Q4 2019. 2,295 funds tracked by Wall St. Rank hold SYK as of Q1 2026.

  • Moors & Cabot held 9,902 shares of Stryker worth $3.25M as of Q1 2026.
  • Moors & Cabot bought 137 Stryker shares in Q1 2026, an estimated $49.2K.
  • Stryker made up 0.14% of Moors & Cabot's portfolio in Q1 2026, its #145 holding.
  • Moors & Cabot first reported a position in Stryker in Q1 2014 and has held it in 49 quarters since.
  • Moors & Cabot's Stryker position peaked at $5.05M in Q4 2019.
  • 2,295 funds tracked by Wall St. Rank held Stryker as of Q1 2026.

Based on Moors & Cabot's 13F filing for Q1 2026, filed 8 May 2026.